QSI Stock Overview
A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Quantum-Si incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.65 |
| 52 Week High | US$5.77 |
| 52 Week Low | US$0.61 |
| Beta | 2.78 |
| 1 Month Change | 37.76% |
| 3 Month Change | 220.76% |
| 1 Year Change | 52.89% |
| 3 Year Change | -54.71% |
| 5 Year Change | n/a |
| Change since IPO | -73.23% |
Recent News & Updates
Quantum-Si: Another Wrong Horse On The Quantum Computing Racetrack - Sell
Jan 04Quantum-Si Isn't A Quantum Computing Company, And Shares Are Overvalued
Dec 29Quantum-Si: Lack Of Commercial Traction Despite Product Upgrades
Dec 16Quantum-Si Is Too Speculative For Me (Technical Analysis)
Nov 26Recent updates
Quantum-Si: Another Wrong Horse On The Quantum Computing Racetrack - Sell
Jan 04Quantum-Si Isn't A Quantum Computing Company, And Shares Are Overvalued
Dec 29Quantum-Si: Lack Of Commercial Traction Despite Product Upgrades
Dec 16Quantum-Si Is Too Speculative For Me (Technical Analysis)
Nov 26Is Quantum-Si (NASDAQ:QSI) In A Good Position To Deliver On Growth Plans?
Nov 06
Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation
Aug 03Quantum-Si (NASDAQ:QSI) Is In A Good Position To Deliver On Growth Plans
Apr 19Quantum-Si: Commercial Lift Imminent
Feb 05Companies Like Quantum-Si (NASDAQ:QSI) Are In A Position To Invest In Growth
Dec 04We Think Quantum-Si (NASDAQ:QSI) Can Afford To Drive Business Growth
Jun 28Jeff Hawkins is the new CEO of Quantum-Si
Oct 04Quantum-Si: Semiconductor-Based Next Generation Protein Sequencing Platform
Sep 24Quantum-Si: Merging Semiconductors With Biology Will Scale Things Fast
Jul 30Proteomics May Be The Future Of Biotech, Quantum-Si Is A Potential Leader
Jul 11Shareholder Returns
| QSI | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -38.3% | 1.8% | -0.5% |
| 1Y | 52.9% | 0.2% | 23.2% |
Return vs Industry: QSI exceeded the US Life Sciences industry which returned 0.2% over the past year.
Return vs Market: QSI exceeded the US Market which returned 23.2% over the past year.
Price Volatility
| QSI volatility | |
|---|---|
| QSI Average Weekly Movement | 52.2% |
| Life Sciences Industry Average Movement | 9.3% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: QSI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: QSI's weekly volatility has increased from 29% to 52% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 159 | Jeff Hawkins | www.quantum-si.com |
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.
Quantum-Si incorporated Fundamentals Summary
| QSI fundamental statistics | |
|---|---|
| Market cap | US$376.76m |
| Earnings (TTM) | -US$89.93m |
| Revenue (TTM) | US$2.27m |
166.6x
P/S Ratio-4.2x
P/E RatioIs QSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QSI income statement (TTM) | |
|---|---|
| Revenue | US$2.27m |
| Cost of Revenue | US$1.10m |
| Gross Profit | US$1.17m |
| Other Expenses | US$91.10m |
| Earnings | -US$89.93m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.63 |
| Gross Margin | 51.54% |
| Net Profit Margin | -3,968.84% |
| Debt/Equity Ratio | 0% |
How did QSI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 23:43 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Quantum-Si incorporated is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyle Mikson | Canaccord Genuity |
| Swayampakula Ramakanth | H.C. Wainwright & Co. |